Idaho’s Legislative Council has approved ballot language for HJR 4, a proposed constitutional amendment on the November ballot that would give only the Legislature the authority to legalize marijuana or other psychoactive substances. https://t.co/mD8bXTWavJ
Idaho’s Legislative Council has approved ballot language for HJR 4, a proposed constitutional amendment on the November ballot that would give only the Legislature the authority to legalize marijuana or other psychoactive substances. https://t.co/mD8bXTWavJ
White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year: Lawmakers should "allow Americans to benefit from access to appropriate full-spectrum CBD products."
https://t.co/UER9Ux0T56
Connecticut Governor Signs Bill To Expand Psychedelics Pilot Program In Preparation For Federal FDA Approval: It broadens eligibility of an existing psychedelic-assisted therapy program involving military veterans and first responders.
https://t.co/27fgtQb3oC
$CBDL continues to broaden its footprint across lucrative verticals, including:
Topicals: 3000mg Pain Relief Cream (now approved on Walmart Marketplace), Anti-Inflammatory Soothe Gel formulated for luxury spa partners
Edibles: Gummies, lozenges, and therapeutic ingestibles with strong consumer reorder rates
Functional Water:
Alkaline CBD hydration products
Nutraceutical Powders: Reishi, lion's mane, and ashwagandha blends designed for stress relief, cognitive support, and inflammation reduction
Veterinarian Wellness:
CBD horse paste and pet-focused formulations designed to support mobility, recovery, and behavioral calm
Each of these categories independently represents annual markets measured in billions - and CBDL is entering all of them with proprietary formulas and growing distribution. @TenAssocLLC
$CBDL - The FDA Authorizes Fruit-Flavored Vapes for Adults 21 and Up Nationwide. CBD Vapes Market size was valued at US$ 5.8 Billion in 2026, and is projected to reach US$ 20.9 Billion by 2033, growing at a CAGR of 20.5% from 2026 to 2033. @TenAssocLLC
https://t.co/QOpiwOkUN9
Yesterday, Congress blocked votes on the 3 amendments that would have preserved legal hemp cannabinoid products before the federal ban takes effect in November.
https://t.co/uK4AJmxkl7
$CBDL @CBDL_StockOTC Leadership Perspective: Positioning for Long-Term Growth
"CBD vapes are emerging as one of the most promising product opportunities in the CBD supplement industry," said Lisa Nelson, President and Chief Executive Officer of CBD Life Sciences Inc. "As ongoing research continues to highlight their potential, we are taking decisive steps to position CBDL as a leader in this growing market. Our commitment remains focused on expanding a strong CBD product ecosystem while creating lasting value for our shareholders."
@TenAssocLLC https://t.co/aHP3dQs7CR
Clinical improvement following an integrative iboga microdosing protocol in post-concussive and hypoxic brain injury syndromes: a case series
https://t.co/bOsIVV56L9
Psychedelics have vast potential to help millions of patients with mental illness. But they aren’t without risks (via @opinion) https://t.co/f91Rt0lNBY
A new study published in Neuroscience found that cannabis-based medicines were associated with significant reductions in tics and premonitory urges among adults with Tourette syndrome. https://t.co/kpR6w10a70
We’re excited to update shareholders more soon. We have more in the works beyond the joint venture with the research facility in Phoenix. Stay tuned! $SNNC
Important RWE: Real-World Psilocybin Therapy for Treatment-Resistant Depression: A Retrospective Observational Study - The Lancet Regional Health – Europe https://t.co/SgLxmamw5q